SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-008583
Filing Date
2019-05-14
Accepted
2019-05-14 16:29:55
Documents
53
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0319_soligenixinc.htm 10-Q 460680
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) ex31_1.htm EX-31.1 10219
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) ex31_2.htm EX-31.2 10057
4 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION ex32_1.htm EX-32.1 3632
5 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION ex32_2.htm EX-32.2 3769
  Complete submission text file 0001213900-19-008583.txt   2881775

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE sngx-20190331.xml EX-101.INS 432885
7 XBRL SCHEMA FILE sngx-20190331.xsd EX-101.SCH 44851
8 XBRL CALCULATION FILE sngx-20190331_cal.xml EX-101.CAL 48086
9 XBRL DEFINITION FILE sngx-20190331_def.xml EX-101.DEF 104453
10 XBRL LABEL FILE sngx-20190331_lab.xml EX-101.LAB 314577
11 XBRL PRESENTATION FILE sngx-20190331_pre.xml EX-101.PRE 212582
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14778 | Film No.: 19823169
SIC: 2834 Pharmaceutical Preparations